Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Blog footer

Digital Pharma: Playing healthcare games

June 23, 2010
Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …

News

Tasigna more effective than Glivec, says Novartis

June 21, 2010
Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …

News

Lucentis boosted by diabetic vision study

May 24, 2010
Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis

A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …

News

Novartis shines in first quarter

April 21, 2010
Sales and Marketing 2010 financials, Alcon, Novartis

Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …

News

Novartis set to boost generic portfolio

April 19, 2010
Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

News

Gilenia cuts relapse rates in MS patients

April 14, 2010
Sales and Marketing Gilena, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia has been shown to reduce relapse rates significantly in new trial data.Data presented …

News
Glivec pack

NICE seeks compromise over Glivec approval

March 24, 2010
Sales and Marketing Glivec, NICE, Novartis

NICE says it is unlikely to approve the use of Glivec against gastrointestinal stromal tumours (GISTs) after surgery, but is …

News
Blog footer

Digital Pharma: Novartis’ transplant community

March 19, 2010
Medical Communications Novartis, PatientsLikeMe, community, digital pharma, digital pharma research, patient information

Novartis has become the second pharma company to partner with PatientsLikeMe on an online community, working with the site on …

News

Tekturna fails to show heart attack benefit

March 17, 2010
Research and Development Diovan, Novartis, Tekturna, hypertension

Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …

News

Novartis buys into Transgene’s lung cancer candidate

March 11, 2010
Research and Development Novartis, Transgene, immunotherapy, lung cancer

French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …

News
Blog footer

Digital Pharma: Novartis tells cystic fibrosis stories

February 25, 2010
Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media

Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …

News
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010
Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …

News

NICE warns industry on cost-effectiveness

February 9, 2010
Sales and Marketing BMS, Janssen, NICE, Novartis, hta

NICE has turned down three drugs on cost grounds and has urged the pharma industry to do more to help …

News
Novartis' Olivier Leupin

Working Life: Olivier Leupin

February 9, 2010
Business Services, Research and Development Novartis, Working Life, careers, careers voice

How did you find your way into your most current role? After receiving a master’s degree in biology at the …

Feature
Jimenez

Jimenez to take over as Novartis chief

January 28, 2010
Sales and Marketing Jimenez, Novartis, Vasella

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025